Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jon D Campbell"'
Publikováno v:
Value in Health. 26:378-383
To evaluate the influence of drug price dynamics in cost-effectiveness analyses (CEAs).We evaluated scenarios involving typical US drug price increases during the exclusivity period and price decreases after the loss of exclusivity (LOE). Worked exam
Autor:
Victoria Lancaster, Marina Richardson, Francesca L Beaudoin, Patricia G Synnott, David M Rind, Belén Herce-Hagiwara, Jon D Campbell, Steven D Pearson
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 28:1316-1320
Autor:
Dmitriy Nikitin, Grace A Lin, Jon D Campbell, Ryan N Hansen, Elizabeth Brouwer, Yilin Chen, Serina Herron-Smith, Foluso Agboola, Steven D Pearson
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 28:680-684
Autor:
David M Rind, R. Brett McQueen, Serina Herron-Smith, Belén Herce-Hagiwara, Eric Gutierrez, Jon D Campbell, Noemi Fluetsch, Steven D Pearson
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 28:577-580
Autor:
Victoria, Lancaster, Marina, Richardson, Francesca L, Beaudoin, Patricia G, Synnott, David M, Rind, Belén, Herce-Hagiwara, Jon D, Campbell, Steven D, Pearson
Publikováno v:
Journal of managed carespecialty pharmacy. 28(11)
Autor:
Dmitriy, Nikitin, Grace A, Lin, Jon D, Campbell, Ryan N, Hansen, Elizabeth, Brouwer, Yilin, Chen, Serina, Herron-Smith, Foluso, Agboola, Steven D, Pearson
Publikováno v:
Journal of managed carespecialty pharmacy. 28(6)
Autor:
David M, Rind, R Brett, McQueen, Serina, Herron-Smith, Belén, Herce-Hagiwara, Eric, Gutierrez, Jon D, Campbell, Noemi, Fluetsch, Steven D, Pearson
Publikováno v:
Journal of managed carespecialty pharmacy. 28(5)
Autor:
Ashley Jaksa, Lisa Bloudek, Josh J. Carlson, Kanya Shah, Yilin Chen, Amanda R. Patrick, Avery McKenna, Jon D. Campbell
Publikováno v:
International Journal of Technology Assessment in Health Care. 38
Health technology assessment (HTA) agencies are considering adopting a lifecycle approach to assessments to address uncertainties in the evidence base at launch and to revisit the clinical and economic value of therapies in a dynamic clinical landsca